Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
March 02, 2012 17:13 ET
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Mar 2, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that it has received clearance by FINRA on...
Boston Therapeutics Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney
January 24, 2012 11:40 ET
|
Boston Therapeutics, Inc.
MANCHESTER, N.H., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (BTI), a developer of diabetes therapeutics, announced today the clinical trial results in healthy volunteers performed at...
Boston Therapeutics Elects Dr. Henry Esber to Its Board of Directors
December 22, 2011 17:00 ET
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Dec 22, 2011) - Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the election of Dr. Henry...